Patent details

EP3555048 Title: NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES

Basic Information

Publication number:
EP3555048
PCT Application Number:
IB2017058081
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178265740
PCT Publication Number:
WO2018116139
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES
French Title of Invention:
NOUVEAUX DÉRIVÉS D'ACIDE PICOLINIQUE ET LEUR UTILISATION EN TANT QU'INTERMÉDIAIRES
German Title of Invention:
NEUE PICOLINSÄUREDERIVATE UND DEREN VERWENDUNG ALS ZWISCHENPRODUKTE
SPC Number:

Dates

Filing date:
18/12/2017
Grant date:
07/07/2021
EP Publication Date:
23/10/2019
PCT Publication Date:
28/06/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/07/2021
EP B1 Publication Date:
07/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2021
Expiration date:
18/12/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/06/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
HEINZ, Thomas
Address:
Switzerland (CH)

2

Name:
MARTIN, Benjamin
Address:
Switzerland (CH)

3

Name:
RAMPF, Florian Andreas
Address:
Switzerland (CH)

4

Name:
ZAUGG, Werner
Address:
Switzerland (CH)

Priority

Priority Number:
201662436222 P
Priority Date:
19/12/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07D 213/79; C07D 213/81;

Publication

European Patent Bulletin

Issue number:
202127
Publication date:
07/07/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages